Myers v. Gilead Sciences, Inc.

District Court, N.D. California·Decided January 21, 2025·No. 3:24-cv-02668·Unknown

Opinion

AMELIA MYERS, et al., Case No. 24-cv-02668-AMO Plaintiffs, ORDER GRANTING IN PART AND v. DENYING IN PART DEFENDANTS’ MOTION TO DISMISS AND/OR STAY GILEAD SCIENCES, INC, et al., PROCEEDINGS Defendants. Re: Dkt. No. 27 This is a putative class action brought by Plaintiffs Amelia Myers and Fatoumata Barry Yapo against their former employers, Defendants Gilead Sciences, Inc. and Kite Pharma, Inc. Myers and Yapo allege that Gilead and Kite Pharma utilized the wrong rate of pay to calculate overtime pay, and thus underpaid overtime in violation of state and federal law. Before the Court is Defendants’ motion to dismiss and/or stay, which was heard on December 19, 2024.1 Having read the papers filed by the parties and carefully considered the arguments therein and those made at the hearing, as well as relevant legal authority, the Court hereby GRANTS IN PART AND DENIES IN PART Defendants’ motion to dismiss and/or stay for the reasons discussed below. I. BACKGROUND2 Plaintiffs formerly worked for Gilead and Kite Pharma in California. FAC ¶¶ 6, 10. They were Cell Therapy Specialists and classified as non-exempt. FAC ¶¶ 7, 11. In addition to hourly wages, Defendants provided Plaintiffs with short-term and annual incentive awards and grants of 1 Also pending before the Court is Plaintiffs’ motion for issuance of notice to the putative class. See ECF 22. The Court will issue a separate order on that motion. 2 The Court accepts Plaintiffs’ allegations in the complaint as true and construes the pleadings in Gilead restricted stock units (“RSUs”) (collectively, “supplemental remuneration”). FAC ¶ 57. The grant of incentive awards is determined by metrics such as employee performance and tenure with the company, while RSUs are non-discretionary and granted primarily based on continued employment. FAC ¶¶ 58-59. Plaintiffs allege they worked overtime, but that no supplemental remuneration was included in the calculations of Plaintiffs’ “regular rates,” and that consequently, Defendants failed to pay all overtime wages to which Plaintiffs were entitled under federal and state law. FAC ¶¶ 62, 64. On May 3, 2024, Plaintiffs filed the instant putative class action against Defendants challenging their alleged underpayment of overtime wages. ECF 1. Plaintiffs allege violations of the California Labor Code and Unfair Competition Law (“UCL”) (collectively, the “state law claims”) on behalf of all non-exempt employees working for Defendants in California, as well as violations of the Fair Labor Standards Act (“FLSA”) on behalf of all current and former non- exempt employees of Defendants in any state. Id. On June 5, 2024, Plaintiffs filed a motion for issuance of court-authorized notice. ECF 22. On June 21, 2024, Defendants moved to dismiss Plaintiffs’ complaint. ECF 27. On July 19, 2024, Defendants opposed Plaintiffs’ motion for issuance of court-authorized notice. ECF 32. On October 15, 2024, the parties stipulated to Plaintiffs’ filing of an amended complaint adding a Private Attorneys General Act (“PAGA”) claim without impacting Defendants’ motion to dismiss. ECF 39. On October 25, 2024, Plaintiffs filed the operative First Amended Complaint (“FAC”). ECF 42. Defendants move to dismiss Plaintiffs’ FAC, arguing Plaintiffs have failed to state a plausible claim for unpaid overtime, and that consequently their claims all fail. Defendants further argue any surviving claims should be stayed in light of ongoing state court litigation involving similar parties, facts, and claims to the instant action. The Court first considers whether staying any of Plaintiffs’ claims is appropriate. It then examines whether any unstayed claims survive Defendants’ motion to dismiss. A. Motion to Stay ongoing action in state court, Herman Pappoe v. Kite Pharma, Inc., et al., No 24STCV02259 (L.A. Super. Ct.), pursuant to the Colorado River doctrine or the Court’s inherent authority in order to avoid duplication of efforts and the risk of conflicting judgments.3 Federal courts may abstain from exercising jurisdiction where “considerations of wise judicial administration, giving regard to conservation of judicial resources and comprehensive disposition of litigation can support a stay of federal litigation in favor of parallel state proceedings.” Ernest Bock, LLC v. Steelman, 76 F.4th 827, 836 (9th Cir. 2023) (citing Colorado River Water Conservation Dist. v. United States, 424 U.S. 800 (1976) (internal quotations omitted)). Stays under Colorado River are “based on administrative concerns and prioritize efficient ‘disposition of litigation’ through the wise deployment of ‘judicial resources.’ ” Id. Courts in the Ninth Circuit assess the following factors to determine whether a Colorado River stay is appropriate: (1) which court first assumed jurisdiction over any property at stake; (2) the inconvenience of the federal forum; (3) the desire to avoid piecemeal litigation; (4) the order in which the forums obtained jurisdiction; (5) whether federal law or state law provides the rule of decision on the merits; (6) whether the state court proceedings can adequately protect the rights of the federal litigants; (7) the desire to avoid forum shopping; and (8) whether the state court proceedings will resolve all issues before the federal court. R.R. St. & Co. Inc. v. Transp. Ins. Co., 656 F.3d 966, 978-79 (9th Cir. 2011). “ ‘Any doubt as to whether a factor exists should be resolved against a stay,’ ” id. at 979, but the factors “are not a ‘mechanical checklist’; indeed, some may not have any applicability to a case,” Seneca Ins. Co.,

Free access — add to your briefcase to read the full text and ask questions with AI

Myers v. Gilead Sciences, Inc., (N.D. Cal. 2025).

Myers v. Gilead Sciences, Inc. (Myers v. Gilead Sciences, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Gulfstream Aerospace Corp. v. Mayacamas Corp.
485 U.S. 271 (Supreme Court, 1988)
Swierkiewicz v. Sorema N. A.
534 U.S. 506 (Supreme Court, 2002)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
RR Street & Co. Inc. v. Transport Ins. Co.
656 F.3d 966 (Ninth Circuit, 2011)
Mendiondo v. Centinela Hospital Medical Center
521 F.3d 1097 (Ninth Circuit, 2008)
Ross v. U.S. Bank National Ass'n
542 F. Supp. 2d 1014 (N.D. California, 2008)
Montanore Minerals Corp. v. Arnold Bakie
867 F.3d 1160 (Ninth Circuit, 2017)
Hagen v. Siouxland Obstetrics & Gynecology, P.C.
23 F. Supp. 3d 991 (N.D. Iowa, 2014)
Goodin v. Vendley
356 F. Supp. 3d 935 (N.D. California, 2018)
Ernest Bock, LLC v. Paul Steelman
76 F.4th 827 (Ninth Circuit, 2023)